Anaplastic astrocytoma cells not detectable on autopsy following long-term temozolomide treatment: A case report
Hirofumi Hirano(Kagoshima University), Kazunori Arita(Kagoshima University)
Cited by 4
Related Papers
Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
|Oncotarget|2013|78
High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme
|British Journal of Cancer|2019|46